Stockreport

ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline [Yahoo! Finance]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF The impending acquisition will add Nimble's lead preclinical asset and a pipeline of other novel oral peptide candidates with potential across several autoimmune disease [Read more]